Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04802720 · ClinicalTrials.gov registry record · NA
A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer
A NA study of Cancer Patients and Family Caregivers, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 348
- Enrollment target
- 5
- Study locations
NCT04802720: Active NA study of Cancer Patients and Family Caregivers, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04802720 is a NA study of Cancer Patients and Family Caregivers that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 348 participants, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (73% higher). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04802720, a NA study of Cancer Patients and Family Caregivers, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 348 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare two types of therapy for caregivers of cancer patients: Emotion Regulation Therapy for Cancer Caregivers (ERT-C) and Cognitive Behavioral Therapy (CBT-C). The researchers want to see if ERT-C is better than, the same as, or worse than traditional CBT-C at improving caregiver distress. The researchers will look at how the two types of therapy affect caregivers' anxiety, depression, and quality of life. The researchers will also see how ERT-C and CBT-C affect hormone and stress levels in caregivers' saliva samples. In addition, this trial will enroll cancer patients in this study to see how their caregivers' participation in ERT-C or CBT may affect the patients' quality of life, stress, and use of healthcare services. Participants who become bereaved while on study will be given the option to withdraw or remain on study. Assessments for bereaved caregivers will not include the Caregiver Quality of Life Index-Cancer (CQOLC) or the Caregiver Reaction Assessment (CRA).
Primary Outcome
as assessed via the HADS Developed by Zigmond and Snaith in 1983, the HADS produces two scales, one for anxiety (HADS-A) and one for depression (HADS-D), differentiating the two states. Items of the overall severity of anxiety and depression are rated on a five-point (0-4) severity scales (ranging from 0 = no not at all, to 4 = yes definitely), for a total score ranging from 0-21 for each subscale. A higher score indicates higher distress
Conditions Studied
Interventions
- OTHER Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C)
- OTHER Emotion Regulation Therapy for Cancer Caregivers (ERT-C)
Study Locations (5)
New York
- Mount Sinai Hospital (Data Analysis Only) - New York
- Columbia University (Data and Specimen Analysis Only) - New York
- Memorial Sloan Kettering Cancer Center - New York
California
- University of California, Irvine (Data and Specimen Analysis Only) - Irvine
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2026-01-08 |
| Phase | NA |
What the registry record for NCT04802720 still lists
NCT04802720 is an interventional study that assigns participants to a tested intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (73% higher).
The record links to 2 conditions, with Cancer Patients appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C) is the first listed.
NCT04802720 lists 5 locations in 3 states (New York, California, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT04802720 about?
NCT04802720 is a clinical study titled "A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer". The purpose of this study is to compare two types of therapy for caregivers of cancer patients: Emotion Regulation Therapy for Cancer Caregivers (ERT-C) and Cognitive Behavioral Therapy (CBT-C). The researchers want to see if ERT-C is better than, the same as, or worse than traditional CBT-C at impr...
What is the current status of trial NCT04802720?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 348 participants. The study started on 2021-02-26. Estimated completion is 2026-01-08.
What conditions does trial NCT04802720 study?
This clinical trial studies the following conditions: Cancer Patients, Family Caregivers.
What interventions are being tested in trial NCT04802720?
The interventions under investigation include: Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C) (OTHER), Emotion Regulation Therapy for Cancer Caregivers (ERT-C) (OTHER).
Who is sponsoring clinical trial NCT04802720?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04802720 being conducted?
This trial has 5 study locations across California, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04802720's enrollment target sits among peer trials
348 2nd of 8 the highest of 8 other Cancer Patients trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Patients trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
RECRUITING · NA
-
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
RECRUITING · NA
-
Writing Intervention With Adolescents and Young Adults With Cancer
RECRUITING · NA
-
Bright IDEAS - Young Adults Problem-Solving Skills Training
ACTIVE NOT RECRUITING · NA
-
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
RECRUITING · Phase 1
-
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
- NCT04530565 · 348 participants · Phase 3
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- NCT05428735 · 348 participants · NA
The DRAGON 2 Trial
- NCT05787379 · 348 participants · NA
Care for Veterans Post-COVID-19
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI